The financials
Genmab A/S by the numbers
Genmab A/S (GMAB) reported revenue of DKK 12.0B in H2 2024 (quarter ended December 31, 2024), up 187% from the same quarter a year earlier. That came with a gross margin of 95% and net income of DKK 5.11B (43% of revenue). For the full year FY2024, revenue was DKK 21.5B (+31% year on year) and net income DKK 7.84B.
| Income statement | H2 2024 | Q2 2023 | Change |
|---|---|---|---|
| Revenue | DKK 12.0B | DKK 4.17B | +187% |
| Gross profit | DKK 11.4B | DKK 4.15B | +174% |
| Operating income | DKK 4.26B | DKK 1.47B | +190% |
| Net income | DKK 5.11B | DKK 1.33B | +283% |
| Diluted EPS | DKK 11.48 | DKK 20.28 | −43% |